Conclusion
Development of acute renal failure during sepsis syndrome is common and portends a poor outcome. The interplay between systemic host responses, local insults in the kidney, vascular bed, and immune system, all play a role in the development of sepsis-induced acute renal failure. Despite advances in critical care, mortality rates have remained high for sepsis-associated acute renal failure. This may be, in part, a function of our poor understanding of the mechanisms of sepsis-induced acute renal failure, leading to misguided management strategies for acute renal failure. Improved understanding of various emerging mechanisms of sepsis-induced acute renal failure such as epithelial barrier dysfunction, apoptosis, and cytokine-mediated injury, should open newer avenues of therapeutic targets in this field. As has often been the case in the study of sepsis, simple universal mechanisms such as tissue perfusion, have failed to explain the diverse and complex clinical response, and therapeutic strategies aimed at single mechanisms have not been successful. The pathophysiologic mechanisms now understood to be operative in sepsis-induced acute renal failure overlap and interact at many levels. Therefore, therapeutic strategies to prevent acute renal failure or to facilitate recovery will likely need to be multifaceted.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
de Mendonca A, Vincent JL, Suter PM, et al (2000) Acute renal failure in the ICU: risk factors and outcome evaluated by the SOFA score. Intensive Care Med 26:915–921
Uchino S, Kellum JA, Bellomo R, et al (2005) Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 294:813–818
Schrier RW, Wang W (2004) Acute renal failure and sepsis. N Engl J Med 351:159–169
Clermont G, Acker CG, Angus DC, Sirio CA, Pinsky MR, Johnson JP (2002) Renal failure in the ICU: comparison of the impact of acute renal failure and end-stage renal disease on ICU outcomes. Kidney Int 62:986–996
Kellum JA, Angus DC (2002) Patients are dying of acute renal failure. Crit Care Med 30:2156–2157
Wan L, Bellomo R, Di Giantomasso D, Ronco C (2003) The pathogenesis of septic acute renal failure. Curr Opin Crit Care 9:496–502
Bonegio R, Lieberthal W (2002) Role of apoptosis in the pathogenesis of acute renal failure. Curr Opin Nephrol Hypertens 11:301–308
Fink MP, Delude RL (2005) Epithelial barrier dysfunction: a unifying theme to explain the pathogenesis of multiple organ dysfunction at the cellular level. Crit Care Clin 21:177–196
Messmer UK, Briner VA, Pfeilschifter J (2000) Basic fibroblast growth factor selectively enhances TNF-alpha-induced apoptotic cell death in glomerular endothelial cells: effects on apoptotic signaling pathways. J Am Soc Nephrol 11:2199–2211
Marshall JC, Vincent JL, Fink MP, et al (2003) Measures, markers, and mediators: toward a staging system for clinical sepsis. A report of the Fifth Toronto Sepsis Roundtable, Toronto, Ontario, Canada, October 25–26, 2000. Crit Care Med 31:1560–1567
Kellum JA, Decker M (2001) Use of dopamine in acute renal failure: a meta-analysis. Crit Care Med 29:1526–1531
Bellomo R, Chapman M, Finfer S, Hickling K, Myburgh J (2000) Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet 356:2139–2143
Kikeri D, Pennell JP, Hwang KH, Jacob AI, Richman AV, Bourgoignie JJ (1986) Endotoxemic acute renal failure in awake rats. Am J Physiol 250:F1098–F1106
Badr KF (1992) Sepsis-associated renal vasoconstriction: potential targets for future therapy. Am J Kidney Dis 20:207–213
Langenberg C, Bellomo R, May C, Wan L, Egi M, Morgera S (2005) Renal blood flow in sepsis. Crit Care 9:R363–R374
Brezis M, Rosen S (1995) Hypoxia of the renal medulla-its implications for disease. N Engl J Med 332:647–655
Di Giantomasso D, Morimatsu H, May CN, Bellomo R (2003) Intrarenal blood flow distribution in hyperdynamic septic shock: Effect of norepinephrine. Crit Care Med 31:2509–2513
Camussi G, Ronco C, Montrucchio G, Piccoli G (1998) Role of soluble mediators in sepsis and renal failure. Kidney Int Suppl 66:S38–S42
Linas SL, Whittenburg D, Repine JE (1991) Role of neutrophil derived oxidants and elastase in lipopolysaccharide-mediated renal injury. Kidney Int 39:618–623
Xia Y, Feng L, Yoshimura T, Wilson CB (1993) LPS-induced MCP-1, IL-1 beta, and TNF-alpha mRNA expression in isolated erythrocyte-perfused rat kidney. Am J Physiol 264:F774–F780
Thijs A, Thijs LG (1998) Pathogenesis of renal failure in sepsis. Kidney Int Suppl 66:S34–S37
Baud L, Oudinet JP, Bens M, et al (1989) Production of tumor necrosis factor by rat mesangial cells in response to bacterial lipopolysaccharide. Kidney Int 35:1111–1118
Kohan DE (1994) Role of endothelin and tumour necrosis factor in the renal response to sepsis. Nephrol Dial Transplant 9Suppl 4:73–77
Messmer UK, Briner VA, Pfeilschifter J (1999) Tumor necrosis factor-alpha and lipopolysaccharide induce apoptotic cell death in bovine glomerular endothelial cells. Kidney Int 55:2322–2337
Knotek M, Rogachev B, Wang W, et al (2001) Endotoxemic renal failure inmice: Role of tumor necrosis factor independent of inducible nitric oxide synthase. Kidney Int 59:2243–2249
van Lanschot JJ, Mealy K, Jacobs DO, Evans DA, Wilmore DW (1991) Splenectomy attenuates the inappropriate diuresis associated with tumor necrosis factor administration. Surg Gynecol Obstet 172:293–297
Cunningham PN, Dyanov HM, Park P, Wang J, Newell KA, Quigg RJ (2002) Acute renal failure in endotoxemia is caused by TNF acting directly on TNF receptor-1 in kidney. J Immunol 168:5817–5823
Rodriguez-Wilhelmi P, Montes R, Matsukawa A, et al (2003) Tumor necrosis factor-alpha inhibition reduces CXCL-8 levels but fails to prevent fibrin generation and does not improve outcome in a rabbit model of endotoxic shock. J Lab Clin Med 141:257–264
Cohen RI, Hassell AM, Marzouk K, Marini C, Liu SF, Scharf SM (2001) Renal effects of nitric oxide in endotoxemia. Am J Respir Crit Care Med 164:1890–1895
Spain DA, Wilson MA, Garrison RN (1994) Nitric oxide synthase inhibition exacerbates sepsis-induced renal hypoperfusion. Surgery 116:322–330
Knotek M, Esson M, Gengaro P, Edelstein CL, Schrier RW (2000) Desensitization of soluble guanylate cyclase in renal cortex during endotoxemia in mice. J Am Soc Nephrol 11:2133–2137
Zimmerman GA, Prescott SM, McIntyre TM (1992) Endothelial cell interactions with granulocytes: tethering and signaling molecules. Immunol Today 13:93–100
Wang J, Dunn MJ (1987) Platelet-activating factor mediates endotoxin-induced acute renal insufficiency in rats. Am J Physiol 253:F1283–F1289
Shimizu T, Kuroda T, Ikeda M, Hata S, Fujimoto M(1998) Potential contribution of endothelin to renal abnormalities in glycerol-induced acute renal failure in rats. J Pharmacol Exp Ther 286:977–983
Forbes JM, Hewitson TD, Becker GJ, Jones CL (2001) Simultaneous blockade of endothelin A and B receptors in ischemic acute renal failure is detrimental to long-term kidney function. Kidney Int 59:1333–1341
Wang W, Jittikanont S, Falk SA, et al (2003) Interaction among nitric oxide, reactive oxygen species, and antioxidants during endotoxemia-related acute renal failure. Am J Physiol Renal Physiol 284:F532–F537
Himmelfarb J, McMonagle E, Freedman S, et al (2004) Oxidative stress is increased in critically ill patients with acute renal failure. J Am Soc Nephrol 15:2449–2456
Stevenson BR (1999) Understanding tight junction clinical physiology at the molecular level. J Clin Invest 104:3–4
Lechner J, Pfaller W (2001) Interferon alpha2b increases paracellular permeability of renal proximal tubular LLC-PK1 cells via a mitogen activated protein kinase signaling pathway. Ren Fail 23:573–588
Lieberthal W, Menza SA, Levine JS (1998) Graded ATP depletion can cause necrosis or apoptosis of cultured mouse proximal tubular cells. Am J Physiol 274:F315–F327
Kaushal GP, Basnakian AG, Shah SV (2004) Apoptotic pathways in ischemic acute renal failure. Kidney Int 66:500–506
Oberbauer R, Rohrmoser M, Regele H, Muhlbacher F, Mayer G (1999) Apoptosis of tubular epithelial cells in donor kidney biopsies predicts early renal allograft function. J Am Soc Nephrol 10:2006–2013
Schumer M, Colombel MC, Sawczuk IS, et al (1992) Morphologic, biochemical, and molecular evidence of apoptosis during the reperfusion phase after brief periods of renal ischemia. Am J Pathol 140:831–838
Dagher PC (2000) Modeling ischemia in vitro: selective depletion of adenine and guanine nucleotide pools. Am J Physiol Cell Physiol 279:C1270–C1277
Kelly KJ, Plotkin Z, Dagher PC (2001) Guanosine supplementation reduces apoptosis and protects renal function in the setting of ischemic injury. J Clin Invest 108:1291–1298
Leist M, Jaattela M (2001) Four deaths and a funeral: from caspases to alternative mechanisms. Nat Rev Mol Cell Biol 2:589–598
Lorz C, Ortiz A, Justo P, et al (2000) Proapoptotic Fas ligand is expressed by normal kidney tubular epithelium and injured glomeruli. J Am Soc Nephrol 11:1266–1277
Meldrum KK, Meldrum DR, Hile KL, et al (2001) p38 MAPK mediates renal tubular cell TNF-alpha production and TNF-alpha-dependent apoptosis during simulated ischemia. Am J Physiol Cell Physiol 281:C563–C570
Feldenberg LR, Thevananther S, del Rio M, de Leon M, Devarajan P (1999) Partial ATP depletion induces Fas-and caspase-mediated apoptosis in MDCK cells. Am J Physiol 276:F837–F846
Jo SK, Cha DR, Cho WY, et al (2002) Inflammatory cytokines and lipopolysaccharide induce Fas-mediated apoptosis in renal tubular cells. Nephron 91:406–415
Carraway MS, Welty-Wolf KE, Miller DL, et al (2003) Blockade of tissue factor: treatment for organ injury in established sepsis. Am J Respir Crit Care Med 167:1200–1209
Bernard GR, Vincent JL, Laterre PF, et al (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344:699–709
Lameire N (2005) The pathophysiology of acute renal failure. Crit Care Clin 21:197–210
Price PM, Megyesi J, Saf Irstein RL (2004) Cell cycle regulation: repair and regeneration in acute renal failure. Kidney Int 66:509–514
Al Awqati Q, Oliver JA (2002) Stem cells in the kidney. Kidney Int 61:387–395
Hammerman MR, Miller SB (1994) Therapeutic use of growth factors in renal failure. J Am Soc Nephrol 5:1–11
Kellum JA (2004) What can be done about acute renal failure? Minerva Anestesiol 70:181–188
Rookmaaker MB, Verhaar MC, van Zonneveld AJ, Rabelink TJ (2004) Progenitor cells in the kidney: biology and therapeutic perspectives. Kidney Int 66:518–522
Poulsom R, Forbes SJ, Hodivala-Dilke K, et al (2001) Bone marrow contributes to renal parenchymal turnover and regeneration. J Pathol 195:229–235
Lange C, Togel F, Ittrich H, et al (2005) Administered mesenchymal stem cells enhance recovery from ischemia/reperfusion-induced acute renal failure in rats. Kidney Int 68:1613–1617
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Raghavan, M., Venkataraman, R., Kellum, J.A. (2007). Sepsis-induced Acute Renal Failure and Recovery. In: Abraham, E., Singer, M. (eds) Mechanisms of Sepsis-Induced Organ Dysfunction and Recovery. Update in Intensive Care and Emergency Medicine, vol 44. Springer, Berlin, Heidelberg . https://doi.org/10.1007/3-540-30328-6_28
Download citation
DOI: https://doi.org/10.1007/3-540-30328-6_28
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-30157-8
Online ISBN: 978-3-540-30328-2
eBook Packages: MedicineMedicine (R0)